| Literature DB >> 25977921 |
Feng-Chiao Tsai1, Guan-Hung Kuo2, Shu-Wei Chang2, Pei-Ju Tsai2.
Abstract
Proper control of Ca(2+) signaling is mandatory for effective cell migration, which is critical for embryonic development, wound healing, and cancer metastasis. However, how Ca(2+) coordinates structural components and signaling molecules for proper cell motility had remained elusive. With the advance of fluorescent live-cell Ca(2+) imaging in recent years, we gradually understand how Ca(2+) is regulated spatially and temporally in migrating cells, driving polarization, protrusion, retraction, and adhesion at the right place and right time. Here we give an overview about how cells create local Ca(2+) pulses near the leading edge, maintain cytosolic Ca(2+) gradient from back to front, and restore Ca(2+) depletion for persistent cell motility. Differential roles of Ca(2+) in regulating various effectors and the interaction of roles of Ca(2+) signaling with other pathways during migration are also discussed. Such information might suggest a new direction to control cancer metastasis by manipulating Ca(2+) and its associating signaling molecules in a judicious manner.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25977921 PMCID: PMC4421034 DOI: 10.1155/2015/409245
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Roles of store-operated Ca2+ (SOC) influx on cancer cell migration.
| Gene(s)/Protein(s) | Cell type | Highlight | Target(s) | Reference |
|---|---|---|---|---|
| ORAI1 | Esophageal squamous cell carcinoma (ESCC) | ORAI1 controls intracellular Ca2+ oscillations | N.A. | [ |
|
| ||||
| ORAI1 and STIM1 | Clear cell renal cell carcinoma (ccRCC) | ORAI1 and STIM1 regulate cell proliferation and migration | N.A. | [ |
|
| ||||
| ORAI1 and STIM2 | Melanoma cell lines | ORAI1 and STIM2 control melanoma growth and invasion in opposite manners | N.A. | [ |
|
| ||||
| ORAI1 | Breast cancer cells | cAMP-PKA pathway decreases SK3 channel and SK3-ORAI1 complex activities, reducing Ca2+ entry and cancer cell migration | cAMP, PKA | [ |
|
| ||||
| STIM1 | Breast cancer cell line MDA-MB-435s | Targeting SK3-ORAI1 in lipid rafts may inhibit bone metastasis | SK3 | [ |
|
| ||||
| STIM1 | Cervical cancer cell lines (SiHa, HT-3, CaSki, and HeLa) | HDAC6 may disrupt STIM1-mediated SOC influx and block malignant cell behavior | HDAC6 | [ |
|
| ||||
| ORAI1 and STIM1 | Glioblastoma multiforme (GBM) | STIM1 and ORAI1 affect the invasion of GBM cells | N.A. | [ |
|
| ||||
| ORAI1 | Human T cell leukemia line, Jurkat cell | Monoclonal antibodies against ORAI1 reduce SOC influx, NFAT transcription, and cytokine release | N.A. | [ |
|
| ||||
| ORAI1 | Human prostate cancer (PCa) cell | Bisphenol A pretreatment enhances SOC influx and ORAI1 protein in LNCaP cells; it also induces PCa cells migration | N.A. | [ |
|
| ||||
| STIM1 | Cervical cancer cell | STIM1 regulates actomyosin reorganization and contractile forces to control cell migration | Actomyosin | [ |
|
| ||||
| STIM1 | Hepatocellular carcinoma and hepatocyte cell lines | STIM1 level predicts prognosis in patients of liver cancer | N.A. | [ |
|
| ||||
| STIM1 | Human epidermoid carcinoma A431 cells | STIM1 regulates SOC influx, cell proliferation, and tumorigenicity | N.A. | [ |
|
| ||||
| STIM1 | Cervical cancer SiHa and CaSki cell lines | STIM1 regulates cervical cancer growth, migration, and angiogenesis | Focal adhesion, Pyk2 | [ |
|
| ||||
| ORAI1 and STIM1 | MDA-MB-231 human breast cancer cells | Blocking STIM1 or ORAI1 using RNA interference or small molecule inhibitors decreased tumor metastasis in animal models | Focal adhesion | [ |
Roles of store-operated SOC influx on the motility of nonmalignant cells.
| Gene(s)/Protein(s) | Cell type | Highlight | Target(s) | Reference |
|---|---|---|---|---|
| STIM1 | Endothelial progenitor cells (EPCs) | STIM1 affects EPCs proliferation and migration after vascular injury by regulating Ca2+ levels | N.A. | [ |
|
| ||||
| ORAI1 | HEK293 | Selective activation of NFAT by ORAI1 | NFAT | [ |
|
| ||||
| STIM1 | Endothelial leader cells | Cells employ an integrated and polarized Ca2+ signalling system for directed cell migration | PLC pathway | [ |
|
| ||||
| ORAI1 | Keratinocytes | ORAI1-mediated Ca2+ entry enhances the turnover of focal adhesion through PKC | PKC pathway | [ |
|
| ||||
| ORAI1 and STIM1 | Retinal pigment epithelial cells (ARPE-19 cell line) | STIM1, ORAI1, ERK 1/2, and Akt determine EGF-mediated cell growth | MAPK pathway | [ |
|
| ||||
| STIM1 | HEK293 | STIM regulates focal adhesion dynamics | Focal adhesion | [ |
|
| ||||
| ORAI1 and STIM1 | Airway smooth muscle cell (ASMC) | STIM1 or ORAI1 controls PDGF-mediated ASMC proliferation and chemotactic migration | N.A. | [ |
|
| ||||
| ORAI1 and STIM1 | ASMC | STIM1 and ORAI1 control PDGF-induced cell migration and Ca2+ influx | N.A. | [ |
|
| ||||
| STIM1 | Intestinal epithelial cell (IEC) | Polyamines control TRPC1-mediated Ca2+ signaling and cell migration via differential STIM1 and STIM2 levels | TRPC1 | [ |
|
| ||||
| ORAI1 and STIM1 | Vascular smooth muscle cells (VSMC) | STIM1- and ORAI1-mediated SOC influx regulates angiotensin II-induced VSMC proliferation | N.A. | [ |
|
| ||||
| STIM1 | EPCs | STIM1 regulates the proliferation and migration of EPCs | N.A. | [ |
|
| ||||
| ORAI1 and STIM1 | VSMC | STIM1 and ORAI1 regulate PDGF-mediated Ca2+ entry and migration in VSMC | N.A. | [ |
|
| ||||
| ORAI1 and STIM1 | VSMC | Knockdown of STIM1 and ORAI1, but not STIM2, Orai2, or Orai3, reduces VSMC proliferation and migration | N.A. | [ |